Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
MP03-36 in Seasonal Allergic Rhinitis
NCT01368445Phase 3Completed
- Sponsor
- Meda
- Start
- Aug 2006
- Primary completion
- Nov 2006
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 3 trial of azelastine in seasonal allergic rhinitis (SAR), sponsored by Meda. Started Aug 2006; status: completed.
02
Drugs
azelastine
03
Conditions
seasonal allergic rhinitis (SAR)
Beyond the preview
Go deeper on NCT01368445.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01368445.